Cibc Private Wealth Group, LLC X4 Pharmaceuticals, Inc Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 45,000 shares of XFOR stock, worth $36,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,000
Previous 45,000
-0.0%
Holding current value
$36,000
Previous $26,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XFOR
# of Institutions
103Shares Held
99.9MCall Options Held
213KPut Options Held
50.6K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$13.5 Million2.03% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$12 Million0.77% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$8.54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.44MShares$6.75 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$5.71 Million0.11% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $54.9M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...